FibroGen, Inc.
FGEN
$8.12
$0.040.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.08M | 1.35M | 2.74M | 3.14M | 123.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.08M | 1.35M | 2.74M | 3.14M | 123.00K |
| Cost of Revenue | 1.15M | 5.95M | 9.43M | 1.03M | 19.90M |
| Gross Profit | -75.00K | -4.60M | -6.69M | 2.11M | -19.78M |
| SG&A Expenses | 5.30M | 7.06M | 8.11M | 8.35M | 9.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.45M | 13.01M | 17.53M | 9.37M | 29.26M |
| Operating Income | -5.37M | -11.66M | -14.79M | -6.23M | -29.14M |
| Income Before Tax | -13.15M | -13.78M | -16.76M | -8.66M | -48.29M |
| Income Tax Expenses | -- | -92.00K | 2.00K | 2.00K | 3.00K |
| Earnings from Continuing Operations | -13.15M | -13.68M | -16.77M | -8.67M | -48.29M |
| Earnings from Discontinued Operations | 213.78M | 6.08M | 21.41M | 26.65M | 31.21M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 200.64M | -7.60M | 4.64M | 17.98M | -17.08M |
| EBIT | -5.37M | -11.66M | -14.79M | -6.23M | -29.14M |
| EBITDA | -5.18M | -11.44M | -14.47M | -5.88M | -28.40M |
| EPS Basic | 49.61 | -1.88 | 1.15 | 4.46 | -4.25 |
| Normalized Basic EPS | -1.01 | -2.07 | -2.58 | -1.20 | -4.62 |
| EPS Diluted | 49.61 | -1.88 | 1.15 | 4.46 | -4.25 |
| Normalized Diluted EPS | -1.01 | -2.07 | -2.58 | -1.20 | -4.62 |
| Average Basic Shares Outstanding | 4.04M | 4.04M | 4.04M | 4.03M | 4.02M |
| Average Diluted Shares Outstanding | 4.04M | 4.04M | 4.04M | 4.03M | 4.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |